. .. Remerciements,

. .. Sommaire,

I. Chapitre, . Le, and .. .. Du-poumon,

. , 'établissement des différents stades du cancer du poumon

I. , La classification des cancers pulmonaires

. , La résistance et l'échapement thérapeutique du cancer bronchique non à petites cellules

I. I. Chapitre and .. .. Les-récepteurs-À-domaine-tyrosine-kinase, Les mécanismes d'activation des récepteurs à domaine tyrosine kinase

I. Chapitre and .. .. La-sortiline, Les sites actifs de trafic dans la séquence de la sortiline

. , La structure du domaine VPS10P de la sortiline

. , 8. La sortiline et la signalisation de mort induite par les pro-neurotrophines

. .. De-la-sortiline, La modulation du trafic des lipoprotéines par la sortiline

. Wilson, « A new role under sortilin's belt in cancer, 2016.

. .. Objectifs,

. Matériels and . .. Méthodes,

. .. Résultats,

I. V. Chapitre, La sortiline contrôle l'internalisation de l'EGFR et limite la croissance tumorale 94

A. Hussein,

E. D. Abel, O. Peroni, J. K. Kim, Y. B. Kim, O. Boss et al., Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver, Nature, vol.409, pp.729-733, 2001.

D. R. Aberle, S. Demello, C. D. Berg, W. C. Black, B. Brewer et al., Results of the two incidence screenings in the National Lung Screening Trial, N. Engl. J. Med, vol.369, pp.920-931, 2013.

C. Abou-fayçal, A. Hatat, S. Gazzeri, and B. Eymin, Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy, Int. J. Mol. Sci, vol.18, 2017.

K. A. Adamczyk, S. Klein-scory, M. M. Tehrani, U. Warnken, W. Schmiegel et al., Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells, Life Sci, vol.89, pp.304-312, 2011.

K. Al-nedawi, B. Meehan, R. S. Kerbel, A. C. Allison, R. et al., Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.3794-3799, 2009.

A. Amini, L. A. Byers, J. W. Welsh, and R. U. Komaki, Progress in the management of limited-stage small cell lung cancer, Cancer, vol.120, pp.790-798, 2014.

R. G. Anderson, The caveolae membrane system, Annu. Rev. Biochem, vol.67, pp.199-225, 1998.

B. Antonny, C. Burd, P. De-camilli, E. Chen, O. Daumke et al., Membrane fission by dynamin: what we know and what we need to know, EMBO J, vol.35, pp.2270-2284, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01597491

M. E. De-araújo, T. Stasyk, N. Taub, H. L. Ebner, B. Fürst et al., Stability of the endosomal scaffold protein LAMTOR3 depends on heterodimer assembly and proteasomal degradation, J. Biol. Chem, vol.288, pp.18228-18242, 2013.

M. E. Arcila, G. R. Oxnard, K. Nafa, G. J. Riely, S. B. Solomon et al., Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.17, pp.1169-1180, 2011.

A. Arkhipov, Y. Shan, R. Das, N. F. Endres, M. P. Eastwood et al., Architecture and membrane interactions of the EGF receptor, Cell, vol.152, pp.557-569, 2013.

D. R. Armant, R. Fritz, B. A. Kilburn, Y. M. Kim, J. K. Nien et al., Reduced Expression of the Epidermal Growth Factor Signaling System in Preeclampsia, Placenta, vol.36, pp.270-278, 2015.

W. T. Arscott and K. A. Camphausen, EGFR isoforms in exosomes as a novel method for biomarker discovery in pancreatic cancer, Biomark. Med, vol.5, p.821, 2011.

Y. S. Aulchenko, S. Ripatti, I. Lindqvist, D. Boomsma, I. M. Heid et al., Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts, Nat. Genet, vol.41, pp.47-55, 2009.

A. S. Azmi, B. Bao, and F. H. Sarkar, Exosomes in Cancer Development, Metastasis and Drug Resistance: A Comprehensive Review, Cancer Metastasis Rev, vol.32, 2013.

A. J. Bannister and T. Kouzarides, Regulation of chromatin by histone modifications, Cell Res, vol.21, pp.381-395, 2011.

F. Barlesi, J. Mazieres, J. Merlio, D. Debieuvre, J. Mosser et al., Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), Lancet Lond. Engl, vol.387, pp.1415-1426, 2016.

W. A. Barton, D. Tzvetkova-robev, E. P. Miranda, M. V. Kolev, K. R. Rajashankar et al., Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex, Nat. Struct. Mol. Biol, vol.13, pp.524-532, 2006.

A. G. Batzer, D. Rotin, J. M. Ureña, E. Y. Skolnik, and J. Schlessinger, Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor, Mol. Cell. Biol, vol.14, pp.5192-5201, 1994.

M. S. Beattie, A. W. Harrington, R. Lee, J. Y. Kim, S. L. Boyce et al., ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury, Neuron, vol.36, pp.375-386, 2002.

C. Bellanger, L. Dubanet, M. Lise, A. Fauchais, D. Bordessoule et al., Endogenous Neurotrophins and Trk Signaling in Diffuse Large B Cell Lymphoma Cell Lines Are Involved in Sensitivity to Rituximab-Induced Apoptosis, PLoS ONE, vol.6, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00873135

V. Bertelsen, M. M. Sak, K. Breen, M. S. Rødland, L. E. Johannessen et al., A chimeric pre-ubiquitinated EGF receptor is constitutively endocytosed in a clathrin-dependent, but kinase-independent manner, Traffic Cph. Den, vol.12, pp.507-520, 2011.

B. G. Bitler, A. Goverdhan, and J. A. Schroeder, MUC1 regulates nuclear localization and function of the epidermal growth factor receptor, J. Cell Sci, vol.123, pp.1716-1723, 2010.

P. Blume-jensen and T. Hunter, Oncogenic kinase signalling, Nature, vol.411, pp.355-365, 2001.

J. L. Boerner, A. Danielsen, and N. J. Maihle, Ligand-independent oncogenic signaling by the epidermal growth factor receptor: v-ErbB as a paradigm, Exp. Cell Res, vol.284, pp.111-121, 2003.

J. S. Bogan, Regulation of glucose transporter translocation in health and diabetes, Annu. Rev. Biochem, vol.81, pp.507-532, 2012.

E. Brambilla, Lung cancer: multidisciplinary approach for management: cell and molecular biology assembly contribution to the celebration of 20 years of the ERS, Eur. Respir. J, vol.35, pp.717-720, 2010.

T. M. Brand, M. Iida, C. Li, and D. L. Wheeler, The nuclear epidermal growth factor receptor signaling network and its role in cancer, Discov. Med, vol.12, pp.419-432, 2011.

B. Brankatschk, S. P. Wichert, S. D. Johnson, O. Schaad, M. J. Rossner et al., Regulation of the EGF transcriptional response by endocytic sorting, Sci. Signal, vol.5, p.21, 2012.

D. A. Bravo, J. B. Gleason, R. I. Sanchez, R. A. Roth, and R. S. Fuller, Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus, J. Biol. Chem, vol.269, pp.25830-25837, 1994.

P. Brest, P. Lapaquette, M. Souidi, K. Lebrigand, A. Cesaro et al., A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease, Nat. Genet, vol.43, pp.242-245, 2011.

J. Bromberg, Stat proteins and oncogenesis, J. Clin. Invest, vol.109, pp.1139-1142, 2002.
DOI : 10.1172/jci15617
URL : http://www.jci.org/articles/view/15617/files/pdf

N. J. Bryant, R. Govers, J. , and D. E. , Regulated transport of the glucose transporter GLUT4, Nat. Rev. Mol. Cell Biol, vol.3, pp.267-277, 2002.
URL : https://hal.archives-ouvertes.fr/hal-01478407

J. Budczies, F. Klauschen, B. V. Sinn, B. Gy?rffy, W. D. Schmitt et al., Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization, PloS One, vol.7, p.51862, 2012.

L. A. Byers and C. M. Rudin, Small cell lung cancer: where do we go from here?, Cancer, vol.121, pp.664-672, 2015.

L. A. Byers, L. Diao, J. Wang, P. Saintigny, L. Girard et al., An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.19, pp.279-290, 2013.

M. K. Callahan, J. D. Wolchok, A. , and J. P. , Anti-CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy, Semin. Oncol, vol.37, pp.473-484, 2010.

, Comprehensive molecular profiling of lung adenocarcinoma, Cancer Genome Atlas Research Network, vol.511, pp.543-550, 2014.

M. Canuel, S. Lefrancois, J. Zeng, and C. R. Morales, AP-1 and retromer play opposite roles in the trafficking of sortilin between the Golgi apparatus and the lysosomes, Biochem. Biophys. Res. Commun, vol.366, pp.724-730, 2008.

X. Cao, H. Zhu, F. Ali-osman, and H. Lo, EGFR and EGFRvIII undergo stressand EGFR kinase inhibitor-induced mitochondrial translocalization: a potential mechanism of EGFR-driven antagonism of apoptosis, Mol. Cancer, vol.10, p.26, 2011.

F. Capuani, A. Conte, E. Argenzio, L. Marchetti, C. Priami et al., Quantitative analysis reveals how EGFR activation and downregulation are coupled in normal but not in cancer cells, Nat. Commun, vol.6, p.7999, 2015.

P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases, Nature, vol.407, pp.249-257, 2000.

C. L. Carpenter, K. R. Auger, M. Chanudhuri, M. Yoakim, B. Schaffhausen et al., Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit, J. Biol. Chem, vol.268, pp.9478-9483, 1993.

G. Carpenter, K. J. Lembach, M. M. Morrison, and S. Cohen, Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts, J. Biol. Chem, vol.250, pp.4297-4304, 1975.

G. Carpenter, L. King, and S. Cohen, Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro, Nature, vol.276, pp.409-410, 1978.

R. E. Carter and A. Sorkin, Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera, J. Biol. Chem, vol.273, pp.35000-35007, 1998.

J. B. Casaletto and A. I. Mcclatchey, Spatial regulation of receptor tyrosine kinases in development and cancer, Nat. Rev. Cancer, vol.12, pp.387-400, 2012.
DOI : 10.1038/nrc3277
URL : http://europepmc.org/articles/pmc3767127?pdf=render

, Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, Centers for Disease Control and Prevention, vol.54, pp.625-628, 1997.

P. Chardin, J. H. Camonis, N. W. Gale, L. Van-aelst, J. Schlessinger et al., Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2, Science, vol.260, pp.1338-1343, 1993.

C. Chen and X. Zhuang, Epsin 1 is a cargo-specific adaptor for the clathrinmediated endocytosis of the influenza virus, Proc. Natl. Acad. Sci. U. S. A, vol.105, p.11790, 2008.

K. Chen, F. Lou, F. Yang, J. Zhang, H. Ye et al., Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by, Targeted Sequencing. Sci. Rep, vol.6, p.31985, 2016.

Z. Chen, C. M. Fillmore, P. S. Hammerman, C. F. Kim, and K. Wong, Non-smallcell lung cancers: a heterogeneous set of diseases, Nat. Rev. Cancer, vol.14, pp.535-546, 2014.

S. Chi, H. Cao, Y. Wang, and M. A. Mcniven, Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15, J. Biol. Chem, vol.286, pp.35196-35208, 2011.

D. Choi, J. O. Park, S. C. Jang, Y. J. Yoon, J. W. Jung et al., Proteomic analysis of microvesicles derived from human colorectal cancer ascites, Proteomics, vol.11, pp.2745-2751, 2011.

Y. L. Choi, M. Soda, Y. Yamashita, T. Ueno, J. Takashima et al., EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors, N. Engl. J. Med, vol.363, pp.1734-1739, 2010.

R. Chou, Y. Wang, Y. Hsieh, L. Li, W. Xia et al., EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4, Dev. Cell, vol.30, pp.224-237, 2014.

B. M. Chung, S. M. Raja, R. J. Clubb, C. Tu, M. George et al., Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src, BMC Cell Biol, vol.10, p.84, 2009.

A. H. Clayton, F. Walker, S. G. Orchard, C. Henderson, D. Fuchs et al., Ligand-induced dimer-tetramer transition during the activation of the cell surface epidermal growth factor receptor-A multidimensional microscopy analysis, J. Biol. Chem, vol.280, pp.30392-30399, 2005.

M. L. Demory, J. L. Boerner, R. Davidson, W. Faust, T. Miyake et al., Epidermal growth factor receptor translocation to the mitochondria: regulation and effect, J. Biol. Chem, vol.284, pp.36592-36604, 2009.

D. Beckler, M. Higginbotham, J. N. Franklin, J. L. Ham, A. Halvey et al., Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS, Mol. Cell. Proteomics MCP, vol.12, pp.343-355, 2013.

K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, U. Raju et al., Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase, J. Biol. Chem, vol.280, pp.31182-31189, 2005.

K. Dittmann, C. Mayer, B. Fehrenbacher, M. Schaller, R. Kehlbach et al., Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654, FEBS Lett, vol.584, pp.3878-3884, 2010.

M. Donepudi and M. D. Resh, c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling, Cell. Signal, vol.20, pp.1359-1367, 2008.

B. J. Druker, Imatinib as a paradigm of targeted therapies, Adv. Cancer Res, vol.91, pp.1-30, 2004.

B. J. Dunmore, K. M. Drake, P. D. Upton, M. R. Toshner, M. A. Aldred et al., The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations, Hum. Mol. Genet, vol.22, pp.3667-3679, 2013.
DOI : 10.1093/hmg/ddt492
URL : https://academic.oup.com/hmg/article-pdf/22/25/5296/1547587/ddt492.pdf

E. R. Eden, I. J. White, A. Tsapara, and C. E. Futter, Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction, Nat. Cell Biol, vol.12, pp.267-272, 2010.
DOI : 10.1038/ncb2026

E. R. Eden, F. Huang, A. Sorkin, and C. E. Futter, The role of EGF receptor ubiquitination in regulating its intracellular traffic, Traffic Cph. Den, vol.13, pp.329-337, 2012.

A. J. Ekstrand, C. D. James, W. K. Cavenee, B. Seliger, R. F. Pettersson et al., Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo, Cancer Res, vol.51, pp.2164-2172, 1991.

A. J. Ekstrand, N. Sugawa, C. D. James, C. , and V. P. , Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N-and/or C-terminal tails, Proc. Natl. Acad. Sci. U. S. A, vol.89, pp.4309-4313, 1992.

M. Emaduddin, M. J. Edelmann, B. M. Kessler, and S. M. Feller, Odin (ANKS1A) is a Src family kinase target in colorectal cancer cells, Cell Commun. Signal. CCS, vol.6, p.7, 2008.

N. F. Endres, R. Das, A. W. Smith, A. Arkhipov, E. Kovacs et al., Conformational Coupling Across the Plasma Membrane in Activation of the EGF receptor, Cell, vol.152, pp.543-556, 2013.

J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland et al., MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling, Science, vol.316, pp.1039-1043, 2007.

D. S. Ettinger, D. E. Wood, W. Akerley, L. A. Bazhenova, H. Borghaei et al., NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4, J. Natl. Compr. Cancer Netw. JNCCN, vol.14, pp.255-264, 2016.

S. F. Evans, K. Irmady, K. Ostrow, T. Kim, A. Nykjaer et al., Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation, J. Biol. Chem, vol.286, pp.29556-29567, 2011.

Q. Fan, C. K. Cheng, W. C. Gustafson, E. Charron, P. Zipper et al., EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma, Cancer Cell, vol.24, pp.438-449, 2013.

S. Fang, W. , and Z. , EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer, Drug Des. Devel. Ther, vol.8, pp.1595-1611, 2014.

E. C. Farlow, K. Patel, S. Basu, B. Lee, A. W. Kim et al., Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.16, pp.3452-3462, 2010.

A. Fauchais, F. Lalloué, M. Lise, A. Boumediene, J. Preud'homme et al., Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival, J. Immunol. Baltim. Md, vol.181, pp.3027-3038, 1950.
URL : https://hal.archives-ouvertes.fr/hal-00453223

N. Fehrenbacher, J. , and M. , Lysosomes as targets for cancer therapy, Cancer Res, vol.65, pp.2993-2995, 2005.

L. Fernandez-cuesta, D. Plenker, H. Osada, R. Sun, R. Menon et al., CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discov, vol.4, pp.415-422, 2014.

G. M. Finan, H. Okada, K. , and T. , BACE1 retrograde trafficking is uniquely regulated by the cytoplasmic domain of sortilin, J. Biol. Chem, vol.286, pp.12602-12616, 2011.

A. R. French, D. K. Tadaki, S. K. Niyogi, and D. A. Lauffenburger, Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction, J. Biol. Chem, vol.270, pp.4334-4340, 1995.

P. Friedl, W. , and K. , Tumour-cell invasion and migration: diversity and escape mechanisms, Nat. Rev. Cancer, vol.3, pp.362-374, 2003.

T. W. Gadella, J. , and T. M. , Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation, J. Cell Biol, vol.129, pp.1543-1558, 1995.

M. Gaestel, MAPKAP kinases-MKs-two's company, three's a crowd, Nat. Rev. Mol. Cell Biol, vol.7, pp.120-130, 2006.

H. K. Gan, A. H. Kaye, and R. B. Luwor, The EGFRvIII variant in glioblastoma multiforme, J. Clin. Neurosci. Off. J. Neurosurg. Soc. Australas, vol.16, pp.748-754, 2009.

I. G. Ganley, P. Wong, N. Gammoh, J. , and X. , Distinct autophagosomallysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest, Mol. Cell, vol.42, pp.731-743, 2011.

M. Gao, R. Patel, I. Ahmad, J. Fleming, J. Edwards et al., SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis, EMBO Mol. Med, vol.4, pp.776-790, 2012.

B. K. Garvalov, F. Foss, A. Henze, I. Bethani, S. Gräf-höchst et al., PHD3 regulates EGFR internalization and signalling in tumours, Nat. Commun, vol.5, p.5577, 2014.

I. Garza-veloz, M. L. Martinez-fierro, J. C. Jaime-perez, K. Carrillo-sanchez, . Ramos-del et al., Identification of Differentially Expressed Genes Associated with Prognosis of B Acute Lymphoblastic Leukemia, Dis. Markers, 2015.

A. Gazdar, Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors, Oncogene, vol.28, pp.24-31, 2009.

A. F. Gazdar, Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy, Cancer Metastasis Rev, vol.29, pp.37-48, 2010.

F. Ghaemimanesh, G. Ahmadian, S. Talebi, A. Zarnani, M. Behmanesh et al., The Effect of Sortilin Silencing on Ovarian Carcinoma Cells, Avicenna J. Med. Biotechnol, vol.6, pp.169-177, 2014.

J. N. Glickman, K. , and S. , Mannose 6-phosphate-independent targeting of lysosomal enzymes in I-cell disease B lymphoblasts, J. Cell Biol, vol.123, pp.99-108, 1993.

J. Gliemann, A. Nykjaer, C. M. Petersen, K. E. Jørgensen, M. Nielsen et al., The multiligand alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP). Binding and endocytosis of fluid phase and membrane-associated ligands, Ann. N. Y. Acad. Sci, vol.737, pp.20-38, 1994.

V. Gocheva, W. Zeng, D. Ke, D. Klimstra, T. Reinheckel et al., Distinct roles for cysteine cathepsin genes in multistage tumorigenesis, Genes Dev, vol.20, pp.543-556, 2006.

L. K. Goh, F. Huang, W. Kim, S. Gygi, and A. Sorkin, Multiple mechanisms collectively regulate clathrin-mediated endocytosis of the epidermal growth factor receptor, J. Cell Biol, vol.189, pp.871-883, 2010.

H. Greulich, T. Chen, W. Feng, P. A. Jänne, J. V. Alvarez et al., Oncogenic transformation by inhibitorsensitive and-resistant EGFR mutants, PLoS Med, vol.2, p.313, 2005.

A. Guillaudeau, K. Durand, B. Bessette, A. Chaunavel, I. Pommepuy et al., EGFR soluble isoforms and their transcripts are expressed in meningiomas, PloS One, vol.7, p.37204, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01819267

A. Gullapalli, T. A. Garrett, M. M. Paing, C. T. Griffin, Y. Yang et al., A Role for Sorting Nexin 2 in Epidermal Growth Factor Receptor Down-regulation: Evidence for Distinct Functions of Sorting Nexin 1 and 2 in Protein Trafficking, Mol. Biol. Cell, vol.15, pp.2143-2155, 2004.

B. Hallberg, S. I. Rayter, and J. Downward, Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation, J. Biol. Chem, vol.269, pp.3913-3916, 1994.

W. Han, R. L. Carpenter, X. Cao, and H. Lo, STAT1 gene expression is enhanced by nuclear EGFR and HER2 via cooperation with STAT3, Mol. Carcinog, vol.52, pp.959-969, 2013.

N. Hanada, H. Lo, C. Day, Y. Pan, Y. Nakajima et al., Coregulation of B-Myb expression by E2F1 and EGF receptor, Mol. Carcinog, vol.45, pp.10-17, 2006.

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

W. Hasan, T. Pedchenko, D. Krizsan-agbas, L. Baum, and P. G. Smith, , 2003.

, Sympathetic neurons synthesize and secrete pro-nerve growth factor protein, J. Neurobiol, vol.57, pp.38-53

E. B. Haura, J. Turkson, J. , and R. , Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer, Nat. Clin. Pract. Oncol, vol.2, pp.315-324, 2005.

Y. He, J. Huang, J. B. Gentry, and C. F. Chignell, Epidermal growth factor receptor down-regulation induced by UVA in human keratinocytes does not require the receptor kinase activity, J. Biol. Chem, vol.278, pp.42457-42465, 2003.

Y. Hegerfeldt, M. Tusch, E. Bröcker, and P. Friedl, Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies, Cancer Res, vol.62, pp.2125-2130, 2002.

L. Henriksen, M. V. Grandal, S. L. Knudsen, B. Van-deurs, and L. M. Grøvdal, Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands, PloS One, vol.8, p.58148, 2013.

R. S. Herbst, J. V. Heymach, and S. M. Lippman, Lung cancer, N. Engl. J. Med, vol.359, pp.1367-1380, 2008.

I. Hermans-borgmeyer, G. Hermey, A. Nykjaer, and C. Schaller, Expression of the 100-kDa neurotensin receptor sortilin during mouse embryonal development, Brain Res. Mol. Brain Res, vol.65, pp.216-219, 1999.

G. Hermey, The Vps10p-domain receptor family, Cell. Mol. Life Sci. CMLS, vol.66, pp.2677-2689, 2009.

G. Hermey, S. S. Sjøgaard, C. M. Petersen, A. Nykjaer, G. et al., Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members, Biochem. J, vol.395, pp.285-293, 2006.

B. Herzberg, M. J. Campo, and J. F. Gainor, Immune Checkpoint Inhibitors in NonSmall Cell Lung Cancer, The Oncologist, vol.22, pp.81-88, 2017.

C. Heurteaux, G. Lucas, N. Guy, M. El-yacoubi, S. Thümmler et al., Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype, Nat. Neurosci, vol.9, pp.1134-1141, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00091223

J. N. Higginbotham, M. Demory-beckler, J. D. Gephart, J. L. Franklin, G. Bogatcheva et al., , 2011.

, Amphiregulin exosomes increase cancer cell invasion, Curr. Biol. CB, vol.21, pp.779-786

C. S. Hill and R. Treisman, Transcriptional regulation by extracellular signals: mechanisms and specificity, Cell, vol.80, pp.199-211, 1995.

F. R. Hirsch, M. Varella-garcia, P. A. Bunn, M. V. Di-maria, R. Veve et al., Epidermal growth factor receptor in nonsmall-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.21, pp.3798-3807, 2003.

C. Hivelin, J. Mazella, and T. Coppola, Sortilin derived propeptide regulation during adipocyte differentiation and inflammation, Biochem. Biophys. Res. Commun, vol.482, pp.87-92, 2017.

M. Hosaka, M. Nagahama, W. S. Kim, T. Watanabe, K. Hatsuzawa et al., Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway, J. Biol. Chem, vol.266, pp.12127-12130, 1991.

S. Hsu, S. A. Miller, Y. Wang, H. , and M. , Nuclear EGFR is required for cisplatin resistance and DNA repair, Am. J. Transl. Res, vol.1, pp.249-258, 2009.

S. Huang and M. P. Czech, The GLUT4 glucose transporter, Cell Metab, vol.5, pp.237-252, 2007.

F. Huang, X. Jiang, and A. Sorkin, Tyrosine phosphorylation of the beta2 subunit of clathrin adaptor complex AP-2 reveals the role of a di-leucine motif in the epidermal growth factor receptor trafficking, J. Biol. Chem, vol.278, pp.43411-43417, 2003.

F. Huang, A. Khvorova, W. Marshall, and A. Sorkin, Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference, J. Biol. Chem, vol.279, pp.16657-16661, 2004.

F. Huang, D. Kirkpatrick, X. Jiang, S. Gygi, and A. Sorkin, Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain, 2006.

, Mol. Cell, vol.21, pp.737-748

F. Huang, L. K. Goh, and A. Sorkin, EGF receptor ubiquitination is not necessary for its internalization, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.16904-16909, 2007.

P. H. Huang, A. M. Xu, and F. M. White, Oncogenic EGFR signaling networks in glioma, Sci. Signal, vol.2, p.6, 2009.

T. Huang, L. Huo, Y. Wang, W. Xia, Y. Wei et al., Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers, Cancer Cell, vol.23, pp.796-810, 2013.

W. Huang, Y. Chen, L. Li, Y. Wei, S. Hsu et al., Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells, J. Biol. Chem, vol.286, pp.20558-20568, 2011.

L. Hung, J. T. Tseng, Y. Lee, W. Xia, Y. Wang et al., Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression, Nucleic Acids Res, vol.36, pp.4337-4351, 2008.

L. Huo, Y. Wang, W. Xia, S. Hsu, C. Lai et al., RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus, Proc. Natl. Acad. Sci. U. S. A, vol.107, pp.16125-16130, 2010.

W. L. Hwu, S. C. Chuang, W. C. Wang, W. , and T. R. , Diagnosis of I-cell disease, 1994.

N. E. Hynes and H. A. Lane, ERBB receptors and cancer: the complexity of targeted inhibitors, Nat. Rev. Cancer, vol.5, pp.341-354, 2005.

J. V. Ilekis, B. C. Stark, and B. Scoccia, Possible role of variant RNA transcripts in the regulation of epidermal growth factor receptor expression in human placenta, Mol. Reprod. Dev, vol.41, pp.149-156, 1995.

M. Ilie, V. Hofman, E. Long-mira, E. Selva, J. Vignaud et al., Sentinel" Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease, PLoS ONE, vol.9, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01687052

S. Jaganathan, P. Yue, D. C. Paladino, J. Bogdanovic, Q. Huo et al., A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells, PLoS ONE, vol.6, 2011.

K. R. Jakobsen, B. S. Paulsen, R. Baek, K. Varming, B. S. Sorensen et al., Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma, J. Extracell. Vesicles, vol.4, p.26659, 2015.

Q. Ji, A. Chattopadhyay, M. Vecchi, and G. Carpenter, Physiological Requirement for Both SH2 Domains for Phospholipase C-?1 Function and Interaction with Platelet-Derived Growth Factor Receptors, Mol. Cell. Biol, vol.19, pp.4961-4970, 1999.
DOI : 10.1128/mcb.19.7.4961
URL : http://mcb.asm.org/content/19/7/4961.full.pdf

I. R. Johnson, E. J. Parkinson-lawrence, T. Shandala, R. Weigert, L. M. Butler et al., Altered Endosome Biogenesis in Prostate Cancer has Biomarker Potential, Mol. Cancer Res. MCR, vol.12, pp.1851-1862, 2014.
DOI : 10.1158/1541-7786.mcr-14-0074
URL : http://mcr.aacrjournals.org/content/molcanres/12/12/1851.full.pdf

I. R. Johnson, E. J. Parkinson-lawrence, H. Keegan, C. D. Spillane, -. Barry et al., , 2015.

, Endosomal gene expression: a new indicator for prostate cancer patient prognosis?, Oncotarget, vol.6, pp.37919-37929

K. F. Johnson, W. Chan, K. , and S. , Cation-dependent mannose 6-phosphate receptor contains two internalization signals in its cytoplasmic domain, Proc. Natl. Acad. Sci. U. S. A, vol.87, pp.10010-10014, 1990.

R. N. Jorissen, F. Walker, N. Pouliot, T. P. Garrett, C. W. Ward et al., Epidermal growth factor receptor: mechanisms of activation and signalling, Exp. Cell Res, vol.284, pp.31-53, 2003.

J. F. Farver and C. F. , Anatomy and Histology of the Lung. In Dail and Hammar's Pulmonary Pathology, pp.20-48, 2008.

N. Karachaliou, J. Codony-servat, C. Teixidó, S. Pilotto, A. Drozdowskyj et al., , 2015.

, BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer, Sci. Rep, vol.5, p.17499

S. Kathiresan, O. Melander, C. Guiducci, A. Surti, N. P. Burtt et al., Six new loci associated with blood lowdensity lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans, Nat. Genet, vol.40, pp.189-197, 2008.

S. Kathiresan, C. J. Willer, G. M. Peloso, S. Demissie, K. Musunuru et al., Common variants at 30 loci contribute to polygenic dyslipidemia, Nat. Genet, vol.41, pp.56-65, 2009.

H. Kawamata, S. Kameyama, and R. Oyasu, In vitro and in vivo acceleration of the neoplastic phenotype of a low-tumorigenicity rat bladder carcinoma cell line by transfected transforming growth factor-alpha, Mol. Carcinog, vol.9, pp.210-219, 1994.

M. Kazazic, K. Roepstorff, L. E. Johannessen, N. M. Pedersen, B. Van-deurs et al., EGF-induced activation of the EGF receptor does not trigger mobilization of caveolae, Traffic Cph. Den, vol.7, pp.1518-1527, 2006.

M. Kazazic, V. Bertelsen, K. W. Pedersen, T. T. Vuong, M. V. Grandal et al., Epsin 1 is involved in recruitment of ubiquitinated EGF receptors into clathrin-coated pits, Traffic Cph. Den, vol.10, pp.235-245, 2009.

E. Kim, Y. Lee, H. Lee, J. S. Kim, B. Song et al., Implication of mouse Vps26b-Vps29-Vps35 retromer complex in sortilin trafficking, Biochem. Biophys. Res. Commun, vol.403, pp.167-171, 2010.

E. S. Kim, M. Neubauer, A. Cohn, L. Schwartzberg, L. Garbo et al., Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial, Lancet Oncol, vol.14, pp.1326-1336, 2013.

H. Kim, Y. Yoon, J. Kim, S. Han, H. Hur et al., Lapatinib, a Dual EGFR and HER2 Tyrosine Kinase Inhibitor, Downregulates Thymidylate Synthase by Inhibiting the Nuclear Translocation of EGFR and HER2, PLoS ONE, vol.4, 2009.

T. Kirkegaard, J. , and M. , Lysosomal involvement in cell death and cancer, Biochim. Biophys. Acta BBA-Mol. Cell Res, vol.1793, pp.746-754, 2009.

M. Kjolby, O. M. Andersen, T. Breiderhoff, A. W. Fjorback, K. M. Pedersen et al., Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export, Cell Metab, vol.12, pp.213-223, 2010.
DOI : 10.1016/j.cmet.2010.08.006
URL : https://doi.org/10.1016/j.cmet.2010.08.006

S. Kornfeld and I. Mellman, The biogenesis of lysosomes, Annu. Rev. Cell Biol, vol.5, pp.483-525, 1989.
DOI : 10.1146/annurev.cellbio.5.1.483

L. Kreyberg, Histological lung cancer types. A morphological and biological correlation, Acta Pathol. Microbiol. Scand. Suppl. Suppl, vol.157, pp.1-92, 1962.

M. G. Kris, B. E. Johnson, L. D. Berry, D. J. Kwiatkowski, A. J. Iafrate et al., Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs, JAMA, vol.311, 1998.

H. Kuo, Y. Chen, H. Chang, J. Jeng, E. Lin et al., The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancer, Carcinogenesis, vol.34, pp.1708-1716, 2013.

T. A. Kupriyanova and K. V. Kandror, Cellugyrin is a marker for a distinct population of intracellular Glut4-containing vesicles, J. Biol. Chem, vol.275, pp.36263-36268, 2000.

G. Lammering, T. H. Hewit, K. Valerie, J. N. Contessa, G. P. Amorino et al., EGFRvIII-mediated radioresistance through a strong cytoprotective response, Oncogene, vol.22, pp.5545-5553, 2003.
DOI : 10.1038/sj.onc.1206788
URL : http://www.nature.com/onc/journal/v22/n36/pdf/1206788a.pdf

L. Roy, C. Wrana, and J. L. , Clathrin-and non-clathrin-mediated endocytic regulation of cell signalling, Nat. Rev. Mol. Cell Biol, vol.6, pp.112-126, 2005.

S. M. Lee, Is EGFR expression important in non-small cell lung cancer?, Thorax, vol.61, pp.98-99, 2006.

H. Lee, L. Lan, G. Peng, W. Chang, M. Hsu et al., Tyrosine 370 phosphorylation of ATM positively regulates DNA damage response, Cell Res, vol.25, pp.225-236, 2015.

R. Lee, P. Kermani, K. K. Teng, and B. L. Hempstead, Regulation of cell survival by secreted proneurotrophins, Science, vol.294, pp.1945-1948, 2001.

M. A. Lemmon and J. Schlessinger, Cell signaling by receptor tyrosine kinases, Cell, vol.141, pp.1117-1134, 2010.

Y. Lemos-gonzález, F. J. Rodríguez-berrocal, O. J. Cordero, C. Gómez, P. De-la-cadena et al., Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma, Br. J. Cancer, vol.96, pp.1569-1578, 2007.

S. A. Leon, B. Shapiro, D. M. Sklaroff, Y. , and M. J. , Free DNA in the serum of cancer patients and the effect of therapy, Cancer Res, vol.37, pp.646-650, 1977.

T. Leu and M. Maa, Functional implication of the interaction between EGF receptor and c-Src, Front. Biosci. J. Virtual Libr, vol.8, pp.28-38, 2003.

X. Li and M. Donowitz, Fractionation of subcellular membrane vesicles of epithelial and nonepithelial cells by OptiPrep density gradient ultracentrifugation, Methods Mol. Biol. Clifton NJ, vol.440, pp.97-110, 2008.

L. Li, T. Zhu, Y. Gao, W. Zheng, C. Wang et al., Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer, Int. J. Mol. Sci, vol.17, 2016.

G. Liccardi, J. A. Hartley, and D. Hochhauser, EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment, Cancer Res, vol.71, pp.1103-1114, 2011.

C. Liebmann, Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity, Cell. Signal, vol.13, pp.777-785, 2001.

B. Z. Lin, P. F. Pilch, and K. V. Kandror, Sortilin is a major protein component of Glut4-containing vesicles, J. Biol. Chem, vol.272, pp.24145-24147, 1997.

S. Y. Lin, K. Makino, W. Xia, A. Matin, Y. Wen et al., Nuclear localization of EGF receptor and its potential new role as a transcription factor, Nat. Cell Biol, vol.3, pp.802-808, 2001.

P. Linsel-nitschke, J. Heeren, Z. Aherrahrou, P. Bruse, C. Gieger et al., Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease, Atherosclerosis, vol.208, pp.183-189, 2010.

Y. Liu, T. Chang, M. Tsai, S. Wu, T. Tsai et al., IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer, Oncotarget, vol.6, pp.10415-10431, 2015.

H. Lo, S. Hsu, M. Ali-seyed, M. Gunduz, W. Xia et al., Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway, Cancer Cell, vol.7, pp.575-589, 2005.

H. Lo, X. Cao, H. Zhu, A. , and F. , COX-2 is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes, Mol. Cancer Res. MCR, vol.8, pp.232-245, 2010.

E. J. Lowenstein, R. J. Daly, A. G. Batzer, W. Li, B. Margolis et al., The SH2 and SH3 domaincontaining protein GRB2 links receptor tyrosine kinases to ras signaling, Cell, vol.70, pp.431-442, 1992.

Y. Lu, C. Futtner, J. R. Rock, X. Xu, W. Whitworth et al., Evidence that SOX2 overexpression is oncogenic in the lung, PloS One, vol.5, p.11022, 2010.

E. Macia, M. Ehrlich, R. Massol, E. Boucrot, C. Brunner et al., , 2006.

, Dynasore, a cell-permeable inhibitor of dynamin, Dev. Cell, vol.10, pp.839-850

I. H. Madshus and E. Stang, Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking, J. Cell Sci, vol.122, pp.3433-3439, 2009.

N. Makrilia, T. Lappa, V. Xyla, I. Nikolaidis, and K. Syrigos, The role of angiogenesis in solid tumours: an overview, Eur. J. Intern. Med, vol.20, pp.663-671, 2009.

S. Maramotti, M. Paci, G. Manzotti, C. Rapicetta, M. Gugnoni et al., Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance, Int. J. Mol. Sci, vol.17, 2016.

E. G. Marcusson, B. F. Horazdovsky, J. L. Cereghino, E. Gharakhanian, and S. D. Emr, The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene, Cell, vol.77, pp.579-586, 1994.

M. Mari, M. V. Bujny, D. Zeuschner, W. J. Geerts, J. Griffith et al., SNX1 defines an early endosomal recycling exit for sortilin and mannose 6-phosphate receptors, Traffic Cph. Den, vol.9, pp.380-393, 2008.

M. Marsh and H. T. Mcmahon, The structural era of endocytosis, Science, vol.285, pp.215-220, 1999.

B. Martin, M. Paesmans, C. Mascaux, T. Berghmans, P. Lothaire et al., Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis, Br. J. Cancer, vol.91, pp.2018-2025, 2004.

S. Martin, V. Navarro, J. P. Vincent, and J. Mazella, Neurotensin receptor-1 and-3 complex modulates the cellular signaling of neurotensin in the HT29 cell line, Gastroenterology, vol.123, pp.1135-1143, 2002.

F. Massa, C. Devader, S. Béraud-dufour, F. Brau, T. Coppola et al., , 2013.

, Focal adhesion kinase dependent activation of the PI3 kinase pathway by the functional soluble form of neurotensin receptor-3 in HT29 cells, Int. J. Biochem. Cell Biol, vol.45, pp.952-959

F. Massa, C. Devader, S. Lacas-gervais, S. Béraud-dufour, T. Coppola et al., Impairement of HT29 Cancer Cells Cohesion by the Soluble Form of Neurotensin Receptor-3, Genes Cancer, vol.5, pp.240-249, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02108990

D. R. Mattoon, B. Lamothe, I. Lax, and J. Schlessinger, The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway, BMC Biol, vol.2, p.24, 2004.

S. Mayor, R. G. Parton, and J. G. Donaldson, Clathrin-Independent Pathways of Endocytosis, Cold Spring Harb. Perspect. Biol, vol.6, 2014.

J. Mazella, P. Kitabgi, and J. P. Vincent, Molecular properties of neurotensin receptors in rat brain. Identification of subunits by covalent labeling, J. Biol. Chem, vol.260, pp.508-514, 1985.

J. Mazella, N. Zsürger, V. Navarro, J. Chabry, M. Kaghad et al., The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor, J. Biol. Chem, vol.273, pp.26273-26276, 1998.

J. Mazella, O. Pétrault, G. Lucas, E. Deval, S. Béraud-dufour et al., Spadin, a Sortilin-Derived Peptide, Targeting Rodent TREK-1 Channels: A New Concept in the Antidepressant Drug Design, vol.8, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00496979

W. J. Mccarthy, R. Meza, J. Jeon, and S. Moolgavkar, Lung cancer in never smokers Epidemiology and risk prediction models, Risk Anal. Off. Publ. Soc. Risk Anal, vol.32, pp.69-84, 2012.

M. Mcclellan, P. Kievit, N. Auersperg, R. , and K. , Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells, Exp. Cell Res, vol.246, pp.471-479, 1999.

J. P. Van-meerbeeck, J. , and A. , The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel? EJC Suppl. EJC Off, J. EORTC Eur. Organ. Res. Treat. Cancer Al, vol.11, pp.150-158, 2013.

T. Mijatovic, P. Gailly, V. Mathieu, N. De-nève, P. Yeaton et al., Neurotensin is a Versatile Modulator of In Vitro Human Pancreatic Ductal Adenocarcinoma Cell (PDAC) Migration, Cell. Oncol. Off. J. Int. Soc. Cell. Oncol, vol.29, pp.315-326, 2007.

S. Mirsadraee, D. Oswal, Y. Alizadeh, A. Caulo, and E. J. Van-beek, The 7th lung cancer TNM classification and staging system: Review of the changes and implications, World J. Radiol, vol.4, pp.128-134, 2012.

W. Mo and J. Zhang, Human ABCG2: structure, function, and its role in multidrug resistance, Int. J. Biochem. Mol. Biol, vol.3, pp.1-27, 2011.

G. Monami, V. Emiliozzi, A. Bitto, F. Lovat, S. Xu et al., Proepithelin Regulates Prostate Cancer Cell Biology by Promoting Cell Growth, Migration, and Anchorage-Independent Growth, Am. J. Pathol, vol.174, pp.1037-1047, 2009.
DOI : 10.2353/ajpath.2009.080735
URL : http://europepmc.org/articles/pmc2665763?pdf=render

A. Morinville, S. Martin, M. Lavallée, J. Vincent, A. Beaudet et al., , 2004.

, Internalization and trafficking of neurotensin via NTS3 receptors in HT29 cells, Int. J. Biochem. Cell Biol, vol.36, pp.2153-2168

D. K. Moscatello, M. Holgado-madruga, A. K. Godwin, G. Ramirez, G. Gunn et al., Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors, Cancer Res, vol.55, pp.5536-5539, 1995.

A. Motley, N. A. Bright, M. N. Seaman, R. , and M. S. , Clathrin-mediated endocytosis in AP-2-depleted cells, J. Cell Biol, vol.162, pp.909-918, 2003.

M. F. Muers and C. E. Round, Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group, Thorax, vol.48, pp.339-343, 1993.

C. Munck-petersen, M. S. Nielsen, C. Jacobsen, J. Tauris, L. Jacobsen et al., Propeptide cleavage conditions sortilin/neurotensin receptor-3 for ligand binding, EMBO J, vol.18, pp.595-604, 1999.

E. A. Musgrove, C. E. Caldon, J. Barraclough, A. Stone, and R. L. Sutherland, Cyclin D as a therapeutic target in cancer, Nat. Rev. Cancer, vol.11, pp.558-572, 2011.

K. Musunuru, A. Strong, M. Frank-kamenetsky, N. E. Lee, T. Ahfeldt et al., From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus, Nature, vol.466, pp.714-719, 2010.

M. Nagane, F. Coufal, H. Lin, O. Bögler, W. K. Cavenee et al., A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis, Cancer Res, vol.56, pp.5079-5086, 1996.

V. Navarro, J. Vincent, and J. Mazella, Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line, Biochem. Biophys. Res. Commun, vol.298, pp.760-764, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00091065

M. S. Nielsen, C. Jacobsen, G. Olivecrona, J. Gliemann, and C. M. Petersen, , 1999.

, Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase, J. Biol. Chem, vol.274, pp.8832-8836

M. S. Nielsen, P. Madsen, E. I. Christensen, A. Nykjaer, J. Gliemann et al., The sortilin cytoplasmic tail conveys Golgiendosome transport and binds the VHS domain of the GGA2 sorting protein, EMBO J, vol.20, pp.2180-2190, 2001.

S. K. Nilsson, S. Christensen, M. K. Raarup, R. O. Ryan, M. S. Nielsen et al., Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families, J. Biol. Chem, vol.283, pp.25920-25927, 2008.

P. C. Nowell, Discovery of the Philadelphia chromosome: a personal perspective, J. Clin. Invest, vol.117, pp.2033-2035, 2007.

A. C. Nyborg, T. B. Ladd, C. W. Zwizinski, J. J. Lah, and T. E. Golde, Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates, Mol. Neurodegener, vol.1, p.3, 2006.

A. Nykjaer and T. E. Willnow, Sortilin: a receptor to regulate neuronal viability and function, Trends Neurosci, vol.35, pp.261-270, 2012.

A. Nykjaer, R. Lee, K. K. Teng, P. Jansen, P. Madsen et al., Sortilin is essential for proNGFinduced neuronal cell death, Nature, vol.427, pp.843-848, 2004.

M. P. Oksvold, H. S. Huitfeldt, A. C. Østvold, and E. Skarpen, UV induces tyrosine kinase-independent internalisation and endosome arrest of the EGF receptor, J. Cell Sci, vol.115, pp.793-803, 2002.

M. P. Oksvold, C. B. Thien, J. Widerberg, A. Chantry, H. S. Huitfeldt et al., UV-radiation-induced internalization of the epidermal growth factor receptor requires distinct serine and tyrosine residues in the cytoplasmic carboxy-terminal domain, Radiat. Res, vol.161, pp.685-691, 2004.

Q. Ouyang, G. Chen, J. Zhou, L. Li, Z. Dong et al., Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p, Neuro-Oncol, vol.18, pp.216-226, 2016.

M. Owada and E. F. Neufeld, Is there a mechanism for introducing acid hydrolases into liver lysosomes that is independent of mannose 6-phosphate recognition? Evidence from I-cell disease, Biochem. Biophys. Res. Commun, vol.105, pp.814-820, 1982.

D. J. Owen, B. M. Collins, and P. R. Evans, Adaptors for clathrin coats: structure and function, Annu. Rev. Cell Dev. Biol, vol.20, pp.153-191, 2004.

J. G. Paez, P. A. Jänne, J. C. Lee, S. Tracy, H. Greulich et al., EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy, Science, vol.304, pp.1497-1500, 2004.

K. H. Paik, S. M. Song, C. S. Ki, H. Yu, J. S. Kim et al., Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA, Hum. Mutat, vol.26, pp.308-314, 2005.

X. Pan, N. Zaarur, M. Singh, P. Morin, and K. V. Kandror, Sortilin and Retromer Mediate Retrograde Transport of Glut4 in 3T3-L1 Adipocytes, Mol. Biol. Cell, 2017.

A. Pandey, B. Blagoev, I. Kratchmarova, M. Fernandez, M. Nielsen et al., Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases, Oncogene, vol.21, pp.8029-8036, 2002.

W. Pao, V. Miller, M. Zakowski, J. Doherty, K. Politi et al., EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.13306-13311, 2004.

J. O. Park, D. Choi, D. Choi, H. J. Kim, J. W. Kang et al., Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions, Proteomics, vol.13, pp.2125-2134, 2013.

S. Y. Park, J. Han, J. B. Kim, M. Yang, Y. J. Kim et al., Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma, Eur. J. Cancer Oxf. Engl, vol.50, pp.341-350, 1990.

D. R. Parkinson, N. Dracopoli, B. G. Petty, C. Compton, M. Cristofanilli et al., Considerations in the development of circulating tumor cell technology for clinical use, J. Transl. Med, vol.10, p.138, 2012.

S. H. Parson, Clinically Oriented Anatomy, 6th edn, J. Anat, vol.215, p.474, 2009.

R. L. Patterson, D. B. Van-rossum, N. Nikolaidis, D. L. Gill, and S. H. Snyder, , 2005.

C. Phospholipase, diverse roles in receptor-mediated calcium signaling, vol.30, pp.688-697

E. F. Patz, M. J. Campa, E. B. Gottlin, I. Kusmartseva, X. R. Guan et al., Panel of serum biomarkers for the diagnosis of lung cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.5578-5583, 2007.

B. M. Pearse, R. , and M. S. , Clathrin, adaptors, and sorting, Annu. Rev. Cell Biol, vol.6, pp.151-171, 1990.

L. Penengo, M. Mapelli, A. G. Murachelli, S. Confalonieri, L. Magri et al., Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin, Cell, vol.124, pp.1183-1195, 2006.

M. Perez-torres, B. L. Valle, N. J. Maihle, L. Negron-vega, R. Nieves-alicea et al., Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells, Exp. Cell Res, vol.314, pp.2907-2918, 2008.

P. Peschard, P. , and M. , Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases, Cancer Cell, vol.3, pp.519-523, 2003.

C. M. Petersen, M. S. Nielsen, A. Nykjaer, L. Jacobsen, N. Tommerup et al., Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography, J. Biol. Chem, vol.272, pp.3599-3605, 1997.

E. C. Piccione, T. J. Lieu, C. F. Gentile, T. R. Williams, A. J. Connolly et al., A novel epidermal growth factor receptor variant lacking multiple domains directly activates transcription and is overexpressed in tumors, Oncogene, vol.31, pp.2953-2967, 2012.

G. Pines, P. H. Huang, Y. Zwang, F. M. White, Y. et al., EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism, Oncogene, vol.29, pp.5850-5860, 2010.

S. Pinet, B. Bessette, N. Vedrenne, A. Lacroix, L. Richard et al., TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells, Oncotarget, vol.7, pp.50349-50364, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01819184

R. Pirker, J. R. Pereira, J. Von-pawel, M. Krzakowski, R. Ramlau et al., EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study, Lancet Oncol, vol.13, pp.33-42, 2012.

M. Polymenidou, C. Lagier-tourenne, K. R. Hutt, S. C. Huelga, J. Moran et al., Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43, Nat. Neurosci, vol.14, pp.459-468, 2011.

H. H. Popper, Progression and metastasis of lung cancer, Cancer Metastasis Rev, vol.35, pp.75-91, 2016.

M. Prudencio, K. R. Jansen-west, W. C. Lee, T. F. Gendron, Y. Zhang et al., Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.21510-21515, 2012.

O. Pylypenko, G. , and B. , Posttranslational modifications of Rab GTPases help their insertion into membranes, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.5555-5556, 2012.

E. M. Quistgaard, P. Madsen, M. K. Grøftehauge, P. Nissen, C. M. Petersen et al., Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain, Nat. Struct. Mol. Biol, vol.16, pp.96-98, 2009.

M. Raica and A. M. Cimpean, Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy, Pharm. Basel Switz, vol.3, pp.572-599, 2010.

J. Z. Rappoport and S. M. Simon, Endocytic trafficking of activated EGFR is AP-2 dependent and occurs through preformed clathrin spots, J. Cell Sci, vol.122, pp.1301-1305, 2009.

M. L. Reitman, A. Varki, K. , and S. , Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-Nacetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity, J. Clin. Invest, vol.67, pp.1574-1579, 1981.

L. Ribassin-majed, G. Le-teuff, and C. Hill, , 2017.

, Bull. Cancer (Paris), vol.104, pp.20-29

H. Riedel, T. J. Dull, J. Schlessinger, and A. Ullrich, A chimaeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor, Nature, vol.324, pp.68-70, 1986.

K. Rikova, A. Guo, Q. Zeng, A. Possemato, J. Yu et al., Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer, Cell, vol.131, pp.1190-1203, 2007.

J. R. Rock, S. H. Randell, and B. L. Hogan, Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling, Dis. Model. Mech, vol.3, pp.545-556, 2010.

G. A. Rodrigues, M. Falasca, Z. Zhang, S. H. Ong, and J. Schlessinger, A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3kinase in epidermal growth factor receptor signaling, Mol. Cell. Biol, vol.20, pp.1448-1459, 2000.

K. Roepstorff, L. Grøvdal, M. Grandal, M. Lerdrup, and B. Van-deurs, Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer, Histochem. Cell Biol, vol.129, pp.563-578, 2008.

K. Roepstorff, M. V. Grandal, L. Henriksen, S. L. Knudsen, M. Lerdrup et al., Differential effects of EGFR ligands on endocytic sorting of the receptor, Traffic Cph. Den, vol.10, pp.1115-1127, 2009.

S. Roselli, J. Pundavela, Y. Demont, S. Faulkner, S. Keene et al., Sortilin is associated with breast cancer aggressiveness and contributes to tumor cell adhesion and invasion, Oncotarget, vol.6, pp.10473-10486, 2015.

W. H. Rostène, A. , and M. J. , Neurotensin and neuroendocrine regulation, Front. Neuroendocrinol, vol.18, pp.115-173, 1997.

M. Russo, S. Misale, G. Wei, G. Siravegna, G. Crisafulli et al., Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer, Cancer Discov, vol.6, pp.36-44, 2016.

C. Sabatti, S. K. Service, A. Hartikainen, A. Pouta, S. Ripatti et al., , 2009.

, Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, Nat. Genet, vol.41, pp.35-46

J. M. Samet, E. Avila-tang, P. Boffetta, L. M. Hannan, S. Olivo-marston et al., LUNG CANCER IN NEVER SMOKERS: CLINICAL EPIDEMIOLOGY AND ENVIRONMENTAL RISK FACTORS. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.15, pp.5626-5645, 2009.

M. P. Sanderson, S. Keller, A. Alonso, S. Riedle, P. J. Dempsey et al., Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion, J. Cell. Biochem, vol.103, pp.1783-1797, 2008.

A. Sandler, R. Gray, M. C. Perry, J. Brahmer, J. H. Schiller et al., Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer, N. Engl. J. Med, vol.355, pp.2542-2550, 2006.

I. V. Sandoval and O. Bakke, Targeting of membrane proteins to endosomes and lysosomes, Trends Cell Biol, vol.4, pp.292-297, 1994.

C. Sanfiorenzo, M. I. Ilie, A. Belaid, F. Barlési, J. Mouroux et al., Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC, PloS One, vol.8, p.54596, 2013.

E. Santos, D. Martin-zanca, E. P. Reddy, M. A. Pierotti, G. Della-porta et al., Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient, Science, vol.223, pp.661-664, 1984.

P. Sarret, P. Krzywkowski, L. Segal, M. S. Nielsen, C. M. Petersen et al., Distribution of NTS3 receptor/sortilin mRNA and protein in the rat central nervous system, J. Comp. Neurol, vol.461, pp.483-505, 2003.

P. J. Saylor, B. Escudier, and M. D. Michaelson, Importance of fibroblast growth factor receptor in neovascularization and tumor escape from antiangiogenic therapy, Clin. Genitourin. Cancer, vol.10, pp.77-83, 2012.

M. Scaltriti, F. Rojo, A. Ocaña, J. Anido, M. Guzman et al., Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer, J. Natl. Cancer Inst, vol.99, pp.628-638, 2007.

C. Schachtrup, J. K. Ryu, K. Mammadzada, A. S. Khan, P. M. Carlton et al., Nuclear pore complex remodeling by p75(NTR) cleavage controls TGF-? signaling and astrocyte functions, Nat. Neurosci, vol.18, pp.1077-1080, 2015.

A. Schenck, L. Goto-silva, C. Collinet, M. Rhinn, A. Giner et al., The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development, Cell, vol.133, pp.486-497, 2008.

J. Schlessinger, Signal transduction by allosteric receptor oligomerization, Trends Biochem. Sci, vol.13, pp.443-447, 1988.

J. Schlöndorff and C. P. Blobel, Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding, J. Cell Sci, vol.112, pp.3603-3617, 1999.

E. V. Schmidt, The role of c-myc in cellular growth control, Oncogene, vol.18, pp.2988-2996, 1999.

J. Schöneberg, I. Lee, J. H. Iwasa, and J. H. Hurley, Reverse-topology membrane scission by the ESCRT proteins, Nat. Rev. Mol. Cell Biol, vol.18, pp.5-17, 2017.

D. C. Schönwasser, R. M. Marais, C. J. Marshall, P. , and P. J. , Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes, Mol. Cell. Biol, vol.18, pp.790-798, 1998.

M. N. Seaman, Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval, J. Cell Sci, vol.120, pp.2378-2389, 2007.

L. V. Sequist, B. A. Waltman, D. Dias-santagata, S. Digumarthy, A. B. Turke et al., Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors, Sci. Transl. Med, vol.3, pp.75-101, 2011.

A. Sgambato, F. Casaluce, P. Maione, A. Rossi, F. Ciardiello et al., , 2014.

, Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?, J. Thorac. Dis, vol.6, pp.578-580

Y. Shan, M. P. Eastwood, X. Zhang, E. T. Kim, A. Arkhipov et al., Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization, Cell, vol.149, pp.860-870, 2012.

R. J. Shaw and L. C. Cantley, Ras, PI(3)K and mTOR signalling controls tumour cell growth, Nature, vol.441, pp.424-430, 2006.

F. A. Shepherd, J. Rodrigues-pereira, T. Ciuleanu, E. H. Tan, V. Hirsh et al., Erlotinib in previously treated non-small-cell lung cancer, N. Engl. J. Med, vol.353, pp.123-132, 2005.

J. Shi and K. V. Kandror, Sortilin is essential and sufficient for the formation of Glut4 storage vesicles in 3T3-L1 adipocytes, Dev. Cell, vol.9, pp.99-108, 2005.

Y. Shiloh and Y. Ziv, The ATM protein kinase: regulating the cellular response to genotoxic stress, and more, Nat. Rev. Mol. Cell Biol, vol.14, pp.197-210, 2013.

K. Shtiegman, B. S. Kochupurakkal, Y. Zwang, G. Pines, A. Starr et al., Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling, Oncogene, vol.26, pp.6968-6978, 2007.

S. Sigismund, T. Woelk, C. Puri, E. Maspero, C. Tacchetti et al., Clathrin-independent endocytosis of ubiquitinated cargos, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.2760-2765, 2005.

S. Sigismund, E. Argenzio, D. Tosoni, E. Cavallaro, S. Polo et al., , 2008.

, Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation, Dev. Cell, vol.15, pp.209-219

S. Sigismund, V. Algisi, G. Nappo, A. Conte, R. Pascolutti et al., Threshold-controlled ubiquitination of the EGFR directs receptor fate, EMBO J, vol.32, pp.2140-2157, 2013.

M. Simon, A. Argiris, and J. R. Murren, Progress in the therapy of small cell lung cancer, Crit. Rev. Oncol. Hematol, vol.49, pp.119-133, 2004.

M. Simons, R. , and G. , Exosomes-vesicular carriers for intercellular communication, Curr. Opin. Cell Biol, vol.21, pp.575-581, 2009.

F. M. Smith, C. Vearing, M. Lackmann, H. Treutlein, J. Himanen et al., Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen, J. Biol. Chem, vol.279, pp.9522-9531, 2004.

M. Soilu-hänninen, P. Ekert, T. Bucci, D. Syroid, P. F. Bartlett et al., Nerve growth factor signaling through p75 induces apoptosis in Schwann cells via a Bcl-2independent pathway, J. Neurosci. Off. J. Soc. Neurosci, vol.19, pp.4828-4838, 1999.

F. Song, M. Zhou, B. Wang, B. Shi, H. Jiang et al., Weak binding to E3 ubiquitin ligase c-Cbl increases EGFRvA protein stability, FEBS Lett, vol.590, pp.1345-1353, 2016.

J. Soria, A. Mauguen, M. Reck, A. B. Sandler, N. Saijo et al., Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as firstline treatment in patients with advanced non-small-cell lung cancer, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.24, pp.20-30, 2013.

A. Sorkin and M. Zastrow, Endocytosis and signalling: intertwining molecular networks, Nat. Rev. Mol. Cell Biol, vol.10, pp.609-622, 2009.

L. P. Sousa, I. Lax, H. Shen, S. M. Ferguson, P. De-camilli et al., Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.4419-4424, 2012.

A. Spira and D. S. Ettinger, Multidisciplinary management of lung cancer, N. Engl. J. Med, vol.350, pp.379-392, 2004.

S. G. Spiro, M. K. Gould, G. L. Colice, and A. , Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines, Chest, vol.132, pp.149-160, 2007.

P. Stephens, C. Hunter, G. Bignell, S. Edkins, H. Davies et al., Lung cancer: intragenic ERBB2 kinase mutations in tumours, Nature, vol.431, pp.525-526, 2004.

K. A. Stern, G. D. Visser-smit, T. L. Place, S. Winistorfer, R. C. Piper et al., , 2007.

, Epidermal Growth Factor Receptor Fate Is Controlled by Hrs Tyrosine Phosphorylation Sites That Regulate Hrs Degradation, Mol. Cell. Biol, vol.27, pp.888-898

K. Su, H. Chen, K. Li, M. Kuo, J. C. Yang et al., Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.30, pp.433-440, 2012.

J. Subramanian, G. , and R. , Lung cancer in never smokers: a review, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.561-570, 2007.

X. Sui, R. Chen, Z. Wang, Z. Huang, N. Kong et al., Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment, Cell Death Dis, vol.4, p.838, 2013.

I. Sullivan, P. , and D. , Next-Generation EGFR Tyrosine Kinase Inhibitors for Treating EGFR-Mutant Lung Cancer beyond First Line, p.76, 2016.

J. M. Summy and G. E. Gallick, Treatment for advanced tumors: SRC reclaims center stage, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.12, pp.1398-1401, 2006.

S. Sun, J. H. Schiller, and A. F. Gazdar, Lung cancer in never smokers-a different disease, Nat. Rev. Cancer, vol.7, pp.778-790, 2007.

R. Sundar, B. Cho, J. R. Brahmer, and R. A. Soo, Nivolumab in NSCLC: latest evidence and clinical potential, Ther. Adv. Med. Oncol, vol.7, pp.85-96, 2015.

G. Sutedja, New techniques for early detection of lung cancer, Eur. Respir. J. Suppl, vol.39, pp.57-66, 2003.

A. Szilágyi and J. Skolnick, Efficient prediction of nucleic acid binding function from low-resolution protein structures, J. Mol. Biol, vol.358, pp.922-933, 2006.

X. Tan, P. F. Lambert, A. C. Rapraeger, A. , and R. A. , Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications, vol.26, pp.352-366, 2016.
DOI : 10.1016/j.tcb.2015.12.006
URL : http://europepmc.org/articles/pmc5120732?pdf=render

M. Tang, M. Wu, M. Hwang, Y. Chang, H. Huang et al., Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells, PLoS ONE, vol.10, 2015.

R. Tanimoto, A. Morcavallo, M. Terracciano, S. Xu, M. Stefanello et al., Sortilin regulates progranulin action in castration-resistant prostate cancer cells, Endocrinology, vol.156, pp.58-70, 2015.

R. Tanimoto, C. Palladino, S. Xu, S. Buraschi, T. Neill et al., The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin, Matrix Biol. J. Int. Soc. Matrix Biol, 2017.

H. K. Teng, K. K. Teng, R. Lee, S. Wright, S. Tevar et al., ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin, J. Neurosci. Off. J. Soc. Neurosci, vol.25, pp.5455-5463, 2005.

T. M. Teslovich, K. Musunuru, A. V. Smith, A. C. Edmondson, I. M. Stylianou et al., Biological, clinical and population relevance of 95 loci for blood lipids, Nature, vol.466, pp.707-713, 2010.

S. Thalappilly, P. Soubeyran, J. L. Iovanna, and N. J. Dusetti, VAV2 regulates epidermal growth factor receptor endocytosis and degradation, Oncogene, vol.29, pp.2528-2539, 2010.
DOI : 10.1038/onc.2010.1
URL : https://www.nature.com/articles/onc20101.pdf

C. Théry, M. Ostrowski, and E. Segura, Membrane vesicles as conveyors of immune responses, Nat. Rev. Immunol, vol.9, pp.581-593, 2009.

M. J. Thun, L. M. Hannan, L. L. Adams-campbell, P. Boffetta, J. E. Buring et al., Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies, PLoS Med, vol.5, 2008.

W. M. Thurlbeck, Post-mortem lung volumes, Thorax, vol.34, pp.735-739, 1979.

T. Tiganis, Protein tyrosine phosphatases: dephosphorylating the epidermal growth factor receptor, IUBMB Life, vol.53, pp.3-14, 2002.

M. Tkach and C. Théry, Communication by Extracellular Vesicles: Where We Are and Where We Need to Go, Cell, vol.164, pp.1226-1232, 2016.

A. Tomas, C. E. Futter, E. , and E. R. , EGF receptor trafficking: consequences for signaling and cancer, Trends Cell Biol, vol.24, pp.26-34, 2014.
DOI : 10.1016/j.tcb.2013.11.002
URL : https://doi.org/10.1016/j.tcb.2013.11.002

A. Tomas, S. O. Vaughan, T. Burgoyne, A. Sorkin, J. A. Hartley et al., WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway, Nat. Commun, vol.6, 2015.

J. Tong, P. Taylor, S. M. Peterman, A. Prakash, and M. F. Moran, Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041, Mol. Cell. Proteomics MCP, vol.8, pp.2131-2144, 2009.

J. Tong, Y. Sydorskyy, J. R. St-germain, P. Taylor, M. S. Tsao et al., , 2013.

. Odin, ANKS1A) modulates EGF receptor recycling and stability, PloS One, vol.8, p.64817

J. Tong, P. Taylor, and M. F. Moran, Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress, Mol. Cell. Proteomics MCP, vol.13, pp.1644-1658, 2014.

M. R. Torrisi, L. V. Lotti, F. Belleudi, R. Gradini, A. E. Salcini et al., Eps15 Is Recruited to the Plasma Membrane upon Epidermal Growth Factor Receptor Activation and Localizes to Components of the Endocytic Pathway during Receptor Internalization, Mol. Biol. Cell, vol.10, pp.417-434, 1999.

D. D. Tran, H. R. Russell, S. L. Sutor, J. Van-deursen, and R. J. Bram, CAML is required for efficient EGF receptor recycling, Dev. Cell, vol.5, pp.245-256, 2003.

W. D. Travis, Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.25, 2012.

W. D. Travis, E. Brambilla, M. Noguchi, A. G. Nicholson, K. R. Geisinger et al., International Multidisciplinary Classification of Lung Adenocarcinoma, J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer, vol.6, pp.244-285, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00561753

I. S. Trowbridge, J. F. Collawn, and C. R. Hopkins, Signal-dependent membrane protein trafficking in the endocytic pathway, Annu. Rev. Cell Biol, vol.9, pp.129-161, 1993.

F. Truzzi, A. Marconi, R. Lotti, K. Dallaglio, L. E. French et al., Neurotrophins and their receptors stimulate melanoma cell proliferation and migration, J. Invest. Dermatol, vol.128, pp.2031-2040, 2008.
DOI : 10.1038/jid.2008.21
URL : https://doi.org/10.1038/jid.2008.21

V. J. Tuominen, S. Ruotoistenmäki, A. Viitanen, M. Jumppanen, and J. Isola, , 2010.

, ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67, Breast Cancer Res. BCR, vol.12, p.56

A. T. Turrisi, K. Kim, R. Blum, W. T. Sause, R. B. Livingston et al., Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide, N. Engl. J. Med, vol.340, pp.265-271, 1999.

A. Ullrich and J. Schlessinger, Signal transduction by receptors with tyrosine kinase activity, Cell, vol.61, pp.203-212, 1990.

A. Ullrich, L. Coussens, J. S. Hayflick, T. J. Dull, A. Gray et al., Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells, Nature, vol.309, pp.418-425, 1984.

H. R. Underhill, J. O. Kitzman, S. Hellwig, N. C. Welker, R. Daza et al., Fragment Length of Circulating Tumor DNA, PLoS Genet, vol.12, 2016.

J. Ursing, L. Rombo, Y. Bergqvist, A. Rodrigues, and P. Kofoed, High-Dose Chloroquine for Treatment of Chloroquine-Resistant Plasmodium falciparum Malaria, J. Infect. Dis, vol.213, pp.1315-1321, 2016.

A. Vaishnavi, M. Capelletti, A. T. Le, S. Kako, M. Butaney et al., Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer, Nat. Med, vol.19, pp.1469-1472, 2013.

P. A. Vanlandingham and B. P. Ceresa, Rab7 Regulates Late Endocytic Trafficking Downstream of Multivesicular Body Biogenesis and Cargo Sequestration, J. Biol. Chem, vol.284, pp.12110-12124, 2009.

M. Vanneman and G. Dranoff, Combining Immunotherapy and Targeted Therapies in Cancer Treatment, Nat. Rev. Cancer, vol.12, pp.237-251, 2012.

S. Vergarajauregui, A. San-miguel, P. , and R. , Activation of p38 mitogenactivated protein kinase promotes epidermal growth factor receptor internalization, Traffic Cph. Den, vol.7, pp.686-698, 2006.

G. Veronesi, E. Bottoni, G. Finocchiaro, A. , and M. , When is surgery indicated for small-cell lung cancer?, Lung Cancer Amst. Neth, vol.90, pp.582-589, 2015.

A. V. Vieira, C. Lamaze, and S. L. Schmid, Control of EGF receptor signaling by clathrin-mediated endocytosis, Science, vol.274, pp.2086-2089, 1996.

J. P. Vincent, J. Mazella, and P. Kitabgi, Neurotensin and neurotensin receptors, Trends Pharmacol. Sci, vol.20, pp.302-309, 1999.
URL : https://hal.archives-ouvertes.fr/hal-00171827

I. Vivanco and C. L. Sawyers, The phosphatidylinositol 3-Kinase AKT pathway in human cancer, Nat. Rev. Cancer, vol.2, pp.489-501, 2002.

A. Waheed, A. Hasilik, and K. Figura, UDP-N-acetylglucosamine:lysosomal enzyme precursor N-acetylglucosamine-1-phosphotransferase. Partial purification and characterization of the rat liver Golgi enzyme, J. Biol. Chem, vol.257, pp.12322-12331, 1982.

C. Wallace, S. J. Newhouse, P. Braund, F. Zhang, M. Tobin et al., Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia, Am. J. Hum. Genet, vol.82, pp.139-149, 2008.

S. Wang, Y. Nakajima, Y. Yu, W. Xia, C. Chen et al., Tyrosine phosphorylation controls PCNA function through protein stability, Nat. Cell Biol, vol.8, pp.1359-1368, 2006.

W. Wang, H. Zhang, S. Liu, C. K. Kim, Y. Xu et al., Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A, Proc. Natl. Acad. Sci. U. S. A, 2017.

X. Wang, Q. Wang, K. L. Ives, and B. M. Evers, Curcumin inhibits neurotensinmediated interleukin-8 production and migration of HCT116 human colon cancer cells, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.12, pp.5346-5355, 2006.

Y. Wang, H. Yamaguchi, J. Hsu, H. , and M. , Nuclear trafficking of the epidermal growth factor receptor family membrane proteins, Oncogene, vol.29, pp.3997-4006, 2010.

C. W. Ward, M. C. Lawrence, V. A. Streltsov, T. E. Adams, and N. M. Mckern, The insulin and EGF receptor structures: new insights into ligand-induced receptor activation, Trends Biochem. Sci, vol.32, pp.129-137, 2007.

J. L. Welton, S. Khanna, P. J. Giles, P. Brennan, I. A. Brewis et al., Proteomics analysis of bladder cancer exosomes, Mol. Cell. Proteomics MCP, vol.9, pp.1324-1338, 2010.

M. A. West, M. S. Bretscher, and C. Watts, Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells, J. Cell Biol, vol.109, pp.2731-2739, 1989.

U. B. Westergaard, E. S. Sørensen, G. Hermey, M. S. Nielsen, A. Nykjaer et al., Functional organization of the sortilin Vps10p domain, J. Biol. Chem, vol.279, pp.50221-50229, 2004.

C. J. Willer, S. Sanna, A. U. Jackson, A. Scuteri, L. L. Bonnycastle et al., Newly identified loci that influence lipid concentrations and risk of coronary artery disease, Nat. Genet, vol.40, pp.161-169, 2008.

C. M. Wilson, T. Naves, F. Vincent, B. Melloni, F. Bonnaud et al., Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors, J. Cell Sci, vol.127, pp.3983-3997, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01059696

C. M. Wilson, T. Naves, H. Al-akhrass, F. Vincent, B. Melloni et al., A new role under sortilin's belt in cancer, Commun. Integr. Biol, vol.9, p.1130192, 2016.

S. Xie, K. Bahl, J. B. Reinecke, G. R. Hammond, N. Naslavsky et al., , 2016.

, The endocytic recycling compartment maintains cargo segregation acquired upon exit from the sorting endosome, Mol. Biol. Cell, vol.27, pp.108-126

J. Xiong, L. Zhou, M. Yang, Y. Lim, Y. Zhu et al., ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro, Neuro-Oncol, vol.15, pp.990-1007, 2013.

T. Yamashita, H. Kamada, S. Kanasaki, Y. Maeda, K. Nagano et al., Epidermal growth factor receptor localized to exosome membranes as a possible biomarker for lung cancer diagnosis, Pharm, vol.68, pp.969-973, 2013.

M. Yang, Y. Lim, X. Li, J. Zhong, and X. Zhou, Precursor of Brain-derived Neurotrophic Factor (proBDNF) Forms a Complex with Huntingtin-associated Protein-1 (HAP1) and Sortilin That Modulates proBDNF Trafficking, Degradation, and Processing, J. Biol. Chem, vol.286, pp.16272-16284, 2011.

Y. Yarden and M. X. Sliwkowski, Untangling the ErbB signalling network, Nat. Rev. Mol. Cell Biol, vol.2, pp.127-137, 2001.

H. Yasuda, E. Park, C. Yun, N. J. Sng, A. R. Lucena-araujo et al., Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer, Sci. Transl. Med, vol.5, pp.216-177, 2013.

T. J. Yeatman, A renaissance for SRC, Nat. Rev. Cancer, vol.4, pp.470-480, 2004.

E. Yong, Cancer biomarkers: Written in blood, Nature, vol.511, pp.524-526, 2014.

M. Younes, Z. Wu, S. Dupouy, A. M. Lupo, N. Mourra et al., Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib, Oncotarget, vol.5, pp.8252-8269, 2014.

H. A. Yu, M. E. Arcila, N. Rekhtman, C. S. Sima, M. F. Zakowski et al., Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy, 2013.

, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.19, pp.2240-2247

J. Yu, X. Ren, Y. Chen, P. Liu, X. Wei et al., Dysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patients, PloS One, vol.8, p.56069, 2013.

Y. Yu, R. Chou, C. Wu, Y. Wang, W. Chang et al., Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776, J. Biol. Chem, vol.287, pp.31015-31026, 2012.

Z. Yuan, Y. Guan, D. Chatterjee, C. , and Y. E. , Stat3 dimerization regulated by reversible acetylation of a single lysine residue, Science, vol.307, pp.269-273, 2005.

Y. Zhang, D. B. Moheban, B. R. Conway, A. Bhattacharyya, and R. A. Segal, Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation, J. Neurosci. Off. J. Soc. Neurosci, vol.20, pp.5671-5678, 2000.

M. Zhou, H. Wang, K. Zhou, X. Luo, X. Pan et al., A novel EGFR isoform confers increased invasiveness to cancer cells, Cancer Res, vol.73, pp.7056-7067, 2013.

S. Zhou, J. D. Schuetz, K. D. Bunting, A. M. Colapietro, J. Sampath et al., The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype, Nat. Med, vol.7, pp.1028-1034, 2001.

F. Van-zijl, G. Krupitza, and W. Mikulits, Initial steps of metastasis: Cell invasion and endothelial transmigration, Mutat. Res, vol.728, pp.23-34, 2011.

L. Zitvogel and G. Kroemer, Targeting PD-1/PD-L1 interactions for cancer immunotherapy, Oncoimmunology, vol.1, pp.1223-1225, 2012.

Y. Zou, Y. Ling, J. Sironi, E. L. Schwartz, R. Perez-soler et al., The autophagy inhibitor chloroquine overcomes the innate resistance to erlotinib of non-small cell lung cancer cells with wild-type EGFR, J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer, vol.8, 2013.

N. Zsürger, J. Mazella, and J. P. Vincent, Solubilization and purification of a high affinity neurotensin receptor from newborn human brain, Brain Res, vol.639, pp.245-252, 1994.

Y. Zwang, Y. , and Y. , p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy, N. Engl. J. Med, vol.25, pp.395-409, 2006.
DOI : 10.1038/sj.emboj.7601297
URL : http://emboj.embopress.org/content/embojnl/25/18/4195.full.pdf